Ipilimumab (Immunotherapy) and MGN1703 (TLR Agonist) in Patients With Advanced Solid Malignancies
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Bayer
ModernaTX, Inc.
OncoNano Medicine, Inc.
Treeline Biosciences, Inc.
Lyell Immunopharma, Inc.
Biogen
City of Hope Medical Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Zai Lab (Hong Kong), Ltd.
Peter MacCallum Cancer Centre, Australia
University of Kansas Medical Center
University of Michigan Rogel Cancer Center
Novartis
Incyte Corporation
Acrotech Biopharma Inc.
Acrotech Biopharma Inc.
Celgene
University of Pittsburgh
University of Louisville
Morphotek
Rutgers, The State University of New Jersey
Case Comprehensive Cancer Center
National Cancer Institute (NCI)
Bristol-Myers Squibb
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Children's Oncology Group
National Cancer Institute (NCI)
Boston Medical Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Northwestern University